Evidence map›Paper›PMID 32409976›Full record

ArticleArchives of dermatological research2021

Follow-up of skin lesions during the evolution of COVID-19: a case report.

Vanessa Lucilia Silveira de Medeiros, Lucas Fagundes Teixeira Silva

Open access · bronzeAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of dermatological research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Cutaneous manifestations of COVID-19: report of three cases.Archives of dermatological research · 2021
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Morbilliform rashes in a patient with COVID-19 infection: A case report.JNMA; journal of the Nepal Medical Association · 2021
    Article
  11. Skin manifestations of COVID-19 in children: Part 2.Clinical and experimental dermatology · 2021
    Review
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Vanessa Lucilia Silveira de MedeirosDermatology Clinic, Tropical Medicine Department of Federal, Clinics Hospital, University of Pernambuco, Av. Prof. Moraes Rego, 1235, Cidade Universitária, Recife, 50670-901, PE, Brazil. vanessalucilia@yahoo.com.br.ORCID http://orcid.org/0000-0002-1445-587X
Lucas Fagundes Teixeira SilvaMedical Faculty of Recife, Centro de Ciências Médicas, Federal University of Pernambuco, Av. da Engenharia, 531-611 - Cidade Universitária, Recife, 50730-120, PE, Brazil.
Universidade Federal de Pernambuco · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The disease caused by the new coronavirus (COVID-19) has many systemic manifestations affecting the upper airways, lungs, gastrointestinal tract and inducing hematological repercussions. With the evolution of the pandemic, skin lesions were observed. However, there is little information about the evolution of the lesions at this moment. The authors report a case of a patient who had more than one exposure to the coronavirus during the evolution of the disease and manifested different types of edematous lesions. The lesions started in the prodromal period and changed their presentation and localization during the evolution of COVID-19. The lesions regressed quickly with the use of corticoid cream and antihistamine. Viral skin lesions are frequent causes of exanthema. However, viral etiology is not always investigated in acute urticarial and atypical erythematous-edematous conditions. The immunological basis of acute urticaria has points in common with COVID-19, justifying the appearance of lesions. Investigation of viral etiology should always be remembered in acute urticarial and edematous conditions.

Indexed as

SARS-CoV-2COVID-19ErythemaFemaleFollow-Up StudiesHumansMiddle AgedSkinUrticariaCOVID-19Emergent infectionsSars-cov-2SkinUrticariaVirus

Identifiers

PMID32409976
PMCPMC7221337
OpenAlexW3025263954

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.